1. Home
  2. GeMigliptin Tartarate

Contact Angene

Tel: +852 8191 6999

Email: [email protected]

Brc1cnc(nc1)C
Pyrimidine, 5-bromo-2-methyl-
CCCP1(=O)OP(=O)(CCC)OP(=O)(O1)CCC
1,3,5,2,4,6-Trioxatriphosphorinane, 2,4,6-tripropyl-, 2,4,6-trioxide
CC1(C)OB(OC1(C)C)B1OC(C(O1)(C)C)(C)C
2,2'-Bi-1,3,2-dioxaborolane, 4,4,4',4',5,5,5',5'-octamethyl-
O=C(C=Cc1ccccc1)C=Cc1ccccc1.O=C(C=Cc1ccccc1)C=Cc1ccccc1.O=C(C=Cc1ccccc1)C=Cc1ccccc1.[Pd].[Pd]
Tris(dibenzylideneacetone)dipalladium
C1CCC(CC1)P(C1CCCCC1)C1CCCCC1.Cc1cc(C)c(c(c1)C)N1CCN(C1=[Ru](=Cc1ccccc1)(Cl)Cl)c1c(C)cc(cc1C)C
Ruthenium,[1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro(phenylmethylene)(tricyclohexylphosphine)-, (SP-5-41)-

GeMigliptin Tartarate

N[C@H](CN1CC(F)(F)CCC1=O)CC(=O)N1CCc2c(C1)nc(nc2C(F)(F)F)C(F)(F)F Request for Quotation
Chemical Name: GeMigliptin Tartarate
CAS Number: 911637-19-9
Product Number: AG00H0I9(AGN-PC-0WAKZV)
Synonyms:
MDL No:
Molecular Formula: C18H19F8N5O2
Molecular Weight: 489.3630

Identification/Properties

Computed Properties
Molecular Weight:
489.37g/mol
XLogP3:
0.7
Hydrogen Bond Donor Count:
1
Hydrogen Bond Acceptor Count:
13
Rotatable Bond Count:
4
Exact Mass:
489.141g/mol
Monoisotopic Mass:
489.141g/mol
Topological Polar Surface Area:
92.4A^2
Heavy Atom Count:
33
Formal Charge:
0
Complexity:
746
Isotope Atom Count:
0
Defined Atom Stereocenter Count:
1
Undefined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Covalently-Bonded Unit Count:
1
Compound Is Canonicalized:
Yes

Safety Information

NMR Spectrum

Other Analytical Data

Request for Quotation

Customer Feedback

Chemical Structure


The compound 1-[(2S)-2-Amino-4-[5,8-dihydro-2,4-bis(trifluoromethyl)pyrido[3,4-d]pyrimidin-7(6H)-yl]-4-oxobutyl]-5,5-difluoro-2-piperidinone can act as a versatile building block in chemical synthesis, specifically in the field of medicinal chemistry and drug development. Its unique structure containing functional groups such as amino, carbonyl, and piperidinone moieties makes it valuable for creating novel pharmaceutical compounds.This compound can be utilized as a key intermediate in the synthesis of potential drug candidates targeting specific biological pathways or receptors. By strategically modifying different regions of the molecule, chemists can tailor its properties to enhance its pharmacological activity, improve bioavailability, or increase selectivity.Furthermore, the presence of fluorine atoms in the structure can impart desirable characteristics such as improved metabolic stability, lipophilicity, and binding affinity. These properties are crucial for increasing the chances of a synthesized compound progressing through preclinical and clinical studies towards becoming a marketable drug.Overall, the application of 1-[(2S)-2-Amino-4-[5,8-dihydro-2,4-bis(trifluoromethyl)pyrido[3,4-d]pyrimidin-7(6H)-yl]-4-oxobutyl]-5,5-difluoro-2-piperidinone in chemical synthesis holds great promise for the development of innovative pharmaceuticals with potential therapeutic benefits.